4.8 Article

Niche and Neutral Effects of Acquired Immunity Permit Coexistence of Pneumococcal Serotypes

期刊

SCIENCE
卷 335, 期 6074, 页码 1376-1380

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1215947

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI048935]
  2. National Institute of General Medical Sciences (NIGMS) [1F32GM097997, U54GM088558]
  3. Pfizer
  4. Novartis
  5. AIR Worldwide
  6. Avian/Pandemic Flu Registry (Outcome Sciences)
  7. Roche

向作者/读者索取更多资源

Over 90 capsular serotypes of Streptococcus pneumoniae, a common nasopharyngeal colonizer and major cause of pneumonia, bacteremia, and meningitis, are known. It is unclear why some serotypes can persist at all: They are more easily cleared from carriage and compete poorly in vivo. Serotype-specific immune responses, which could promote diversity in principle, are weak enough to allow repeated colonizations by the same type. We show that weak serotype-specific immunity and an acquired response not specific to the capsule can together reproduce observed diversity. Serotype-specific immunity stabilizes competition, and acquired immunity to noncapsular antigens reduces fitness differences. Our model can be used to explain the effects of pneumococcal vaccination and indicates general factors that regulate the diversity of pathogens.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据